SI1507798T1 - Izvoz in modifikacija (poli)peptidov na lantibiotični način - Google Patents

Izvoz in modifikacija (poli)peptidov na lantibiotični način

Info

Publication number
SI1507798T1
SI1507798T1 SI200332339T SI200332339T SI1507798T1 SI 1507798 T1 SI1507798 T1 SI 1507798T1 SI 200332339 T SI200332339 T SI 200332339T SI 200332339 T SI200332339 T SI 200332339T SI 1507798 T1 SI1507798 T1 SI 1507798T1
Authority
SI
Slovenia
Prior art keywords
lantibiotic
peptides
export
poly
modification
Prior art date
Application number
SI200332339T
Other languages
English (en)
Inventor
Gert Nikolaas Moll
Cornelis Johannes Leenhouts
Oscar Paul Kuipers
Arnold Jacob Mathieu Driessen
Original Assignee
Lanthiopep B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30011145&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1507798(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lanthiopep B.V. filed Critical Lanthiopep B.V.
Publication of SI1507798T1 publication Critical patent/SI1507798T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200332339T 2002-05-24 2003-05-26 Izvoz in modifikacija (poli)peptidov na lantibiotični način SI1507798T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02077060 2002-05-24
US10/360,101 US6861236B2 (en) 2002-05-24 2003-02-07 Export and modification of (poly)peptides in the lantibiotic way
PCT/NL2003/000389 WO2003099862A1 (en) 2002-05-24 2003-05-26 Export and modification of (poly)peptides in the lantibiotic way
EP03733622.9A EP1507798B2 (en) 2002-05-24 2003-05-26 Export and modification of (poly)peptides in the lantibiotic way

Publications (1)

Publication Number Publication Date
SI1507798T1 true SI1507798T1 (sl) 2014-05-30

Family

ID=30011145

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332339T SI1507798T1 (sl) 2002-05-24 2003-05-26 Izvoz in modifikacija (poli)peptidov na lantibiotični način

Country Status (11)

Country Link
US (1) US6861236B2 (sl)
EP (1) EP1507798B2 (sl)
CN (1) CN1671737B (sl)
AU (1) AU2003238714A1 (sl)
CA (1) CA2487351C (sl)
CY (1) CY1114998T1 (sl)
DK (1) DK1507798T4 (sl)
ES (1) ES2444840T5 (sl)
PT (1) PT1507798E (sl)
SI (1) SI1507798T1 (sl)
WO (1) WO2003099862A1 (sl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175821A1 (en) * 1999-05-17 2009-07-09 Bridon Dominique P Modified therapeutic peptides with extended half-lives in vivo
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
EP1789440A4 (en) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
GB0406870D0 (en) * 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
US7592308B2 (en) 2004-03-26 2009-09-22 Novacta Biosystems Limited F3W variants of the lantibiotic mersacidin and its use
EP2100904B1 (en) * 2004-04-23 2010-07-07 ConjuChem Biotechnologies Inc. Solid phase for use in a method for the purification of albumin conjugates
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
DK1819816T3 (da) * 2004-12-07 2009-01-26 Applied Nanosystems Bv Fremgangsmåder til fremstilling og udskillelse af modificerede peptider
WO2007000332A2 (en) * 2005-06-29 2007-01-04 Biotech Concepts Gmbh Biosynthetic process for the preparation of gallidermin
US8039432B2 (en) * 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
EP1976876A4 (en) * 2005-12-22 2010-01-13 Conjuchem Biotechnologies Inc PROCESS FOR PRODUCING PREFORMED ALBUMIN CONJUGATES AND THERAPEUTIC AGENT
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
RU2415149C2 (ru) * 2006-02-10 2011-03-27 Ферринг Б.В. Пептидные соединения
MX2009000800A (es) * 2006-07-21 2009-04-16 Cristalia Prod Quimicos Farm Peptidos ciclicos anti-inflamatorios y anti-alergicos.
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
EP2175874A2 (en) * 2007-08-14 2010-04-21 Ferring B.V. Use of peptidic vasopressin receptor agonists
SG185263A1 (en) 2007-09-28 2012-11-29 Portola Pharm Inc Antidotes for factor xa inhibitors and methods of using the same
CA2708762A1 (en) * 2007-12-11 2009-06-18 Conjuchem Biotechnologies Inc. Formulation of insulinotropic peptide conjugates
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
KR20110086582A (ko) * 2008-11-24 2011-07-28 센티넬라 파마세티컬즈, 인크. 항균활성이 강화된 란티바이오틱 카르복시아미드 유도체
CN102348718B (zh) 2009-01-14 2015-06-03 诺瓦克塔生物系统有限公司 去氧阿肽加定衍生物
EP2393829A1 (en) 2009-02-04 2011-12-14 Novacta Biosystems Limited Actagardine derivatives
HUE057174T2 (hu) * 2009-05-20 2022-04-28 Biomarin Pharm Inc A C-típusú nátriuretikus peptid variánsai
EP2267003A1 (en) * 2009-06-24 2010-12-29 Applied NanoSystems B.V. Biologically produced cyclic affinity tags
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US9714943B2 (en) * 2010-12-30 2017-07-25 University Of South Florida Methods and materials for capture antibody targeted fluorescent in-situ hybridization (CAT-FISH)
US9976133B2 (en) 2012-06-20 2018-05-22 The Regents Of The University Of California Synzymes
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
CN104902920A (zh) 2012-12-21 2015-09-09 赛诺菲 作为glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂的毒蜥外泌肽-4衍生物
CN104211802B (zh) * 2013-05-29 2018-07-27 成都渊源生物科技有限公司 人凝血因子轻链蛋白及其应用
WO2015086730A1 (en) 2013-12-13 2015-06-18 Sanofi Non-acylated exendin-4 peptide analogues
TW201609795A (zh) 2013-12-13 2016-03-16 賽諾菲公司 作為雙重ｇｌｐ－１／ｇｉｐ受體促效劑的艾塞那肽－４（ｅｘｅｎｄｉｎ－４）胜肽類似物
EP3080149A1 (en) 2013-12-13 2016-10-19 Sanofi Dual glp-1/glucagon receptor agonists
WO2015086729A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/gip receptor agonists
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
US9995758B1 (en) 2014-10-31 2018-06-12 Western Autotroph Company LLC Methods and systems for controlling oxidative stress in humans and animals
US20170267981A1 (en) * 2014-12-05 2017-09-21 Danisco Us Inc. Compositions and methods comprising the use of a bacillus agaradhaerens inulosucrase (inuo)
MX2017011654A (es) * 2015-03-13 2018-02-09 Lanthiopep Bv Analogos ciclicos de galanina y usos de los mismos.
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105284A1 (es) 2015-07-10 2017-09-20 Sanofi Sa Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
CN106366168B (zh) * 2016-08-26 2020-09-15 上海交通大学 羊毛硫肽类抗菌肽及其脱氢衍生物的制备方法
CN106589135B (zh) * 2016-11-25 2018-08-28 东北农业大学 一种靶向抗菌肽及其制备方法和应用
CN110627880B (zh) * 2018-06-25 2024-03-19 武汉合生科技有限公司 分离的多肽及其应用
AU2020395323A1 (en) * 2019-12-06 2022-06-30 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor VIII function
WO2022202785A1 (ja) * 2021-03-22 2022-09-29 美智子 甲賀 ポリペプチド並びにそれを含む細胞融合剤及びがん治療用医薬組成物
CN113354718B (zh) * 2021-06-21 2023-06-02 重庆市畜牧科学院 一种哌尼生素前体、表达盒及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837485A (en) 1988-05-18 1998-11-17 Dr. Karl Tomae Gmbh DNA encoding and biosynthetic process for the preparation of chemical compounds, lantibiotics
GB8811760D0 (en) 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
GB8811761D0 (en) 1988-05-18 1988-06-22 Thomae Gmbh Dr K Biosynthetic process for preparation of chemical compounds
US5218101A (en) 1988-07-05 1993-06-08 The University Of Maryland Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
US5516682A (en) 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
IN167138B (sl) 1988-08-17 1990-09-01 Hoechst India
IE910663A1 (en) 1990-02-28 1991-08-28 Gist Brocades Nv Improved processing of proteins
EP0579730B1 (en) 1991-04-11 2003-02-26 Stichting Nederlands Instituut Voor Zuivelonderzoek (Nizo) Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics
WO1993003058A2 (en) 1991-07-01 1993-02-18 University Technologies International Inc. NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS
US6028168A (en) 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
WO1993003056A1 (en) 1991-08-09 1993-02-18 Winfried Kolbeck Lanthionine bridged peptides
CA2081704C (en) 1991-10-31 2007-05-01 Karl-Dieter Entian Biosynthetic process for the preparation of lantibiotics
GB9207267D0 (en) 1992-04-02 1992-05-13 Agricultural & Food Res Nisins
GB2282813A (en) 1993-10-15 1995-04-19 Merck & Co Inc Annular antigen scaffolds comprising thioether linkages
US5872001A (en) 1994-04-20 1999-02-16 Uab Research Foundation Lanthionine antibiotic compositions and methods
US5650320A (en) 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
EP0700998B1 (en) 1994-09-12 2003-11-26 Aventis Pharma Deutschland GmbH Recombinant mersacidin and a method for production
DE69527126T2 (de) 1994-11-18 2002-12-12 Stichting Nederlands Instituut Voor Zuivelonderzoek, Ede Verfahren zur Kontrolle der Genexpression in Milchsäurebakterien
GB9423404D0 (en) 1994-11-19 1995-01-11 Biotech & Biolog Scien Res Production of nisin
IES70514B2 (en) 1995-04-12 1996-12-11 Teagasc Agric Food Dev Authori Bacteriocins
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5861275A (en) * 1995-09-28 1999-01-19 The University Of Maryland Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same
US5817752A (en) * 1996-06-06 1998-10-06 La Jolla Pharmaceutical Company Cyclic polypeptides comprising a thioether linkage and methods for their preparation
US5786197A (en) 1996-11-25 1998-07-28 Smithkline Beecham Corporation lep
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6541607B1 (en) 1997-07-18 2003-04-01 University Of Maryland Sublancin lantibiotic produced by Bacillus subtilis 168
US6218362B1 (en) 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
CA2209893A1 (en) 1997-09-08 1999-03-08 Christophe Lacroix Lantibiotic from streptococcus mutans, method of production and use thereof
DE19745583A1 (de) 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
GB9902399D0 (en) 1999-02-03 1999-03-24 Smithkline Beecham Plc Compounds
CA2363713C (en) 1999-10-12 2007-11-06 Blis Technologies Limited Lantibiotic
US6759205B2 (en) 2000-06-29 2004-07-06 University Of Maryland Construction of a strain of Bacillus subtilis 168 that displays the sublancin lantibiotic on the surface of the cell
US6342385B1 (en) 2000-07-28 2002-01-29 The Uab Research Foundation Mutacin I biosynthesis genes and proteins
WO2002020610A2 (en) 2000-09-07 2002-03-14 Biosynthema Inc. Conformationally constrained labeled peptides for imaging and therapy

Also Published As

Publication number Publication date
EP1507798B2 (en) 2016-11-16
WO2003099862A1 (en) 2003-12-04
AU2003238714A1 (en) 2003-12-12
DK1507798T3 (en) 2014-02-24
CA2487351C (en) 2013-07-23
CN1671737B (zh) 2011-12-28
ES2444840T5 (es) 2017-06-01
PT1507798E (pt) 2014-02-24
AU2003238714A8 (en) 2003-12-12
CN1671737A (zh) 2005-09-21
WO2003099862A8 (en) 2004-03-11
CA2487351A1 (en) 2003-12-04
CY1114998T1 (el) 2016-12-14
DK1507798T4 (en) 2017-02-13
EP1507798B1 (en) 2013-11-20
US20040009550A1 (en) 2004-01-15
US6861236B2 (en) 2005-03-01
EP1507798A1 (en) 2005-02-23
ES2444840T3 (es) 2014-02-27

Similar Documents

Publication Publication Date Title
AU2003238714A8 (en) Export and modification of (poly)peptides in the lantibiotic way
HUP0500989A2 (en) Animicrobial polypeptides and their uses
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
EP1462455A4 (en) NOVEL PEPTIDES AND THEIR USES AS MEDICAMENTS
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
AU2003211163A8 (en) Partial peptide mimetics and methods
EP1476176A4 (en) TRANSPORT PEPTIDES AND ITS USE
GB0309064D0 (en) Modified peptides and their uses
AU2003290886A8 (en) Modified alpha-msh peptides and derivatives thereof
HK1209049A1 (en) Survivin-derived peptides and use thereof
IL152609A0 (en) Liposomal compositions comprising haptotactic peptides and uses thereof
EP1699809A4 (en) PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF
EP1395276A4 (en) STRUCTURALLY MODIFIED PEPTIDES AND THEIR USE
GB0223860D0 (en) Polypeptide methods and means
IL149179A0 (en) FcyRII-BINDING PEPTIDES AND USES THEREOF
GB0222255D0 (en) Peptides and their use
IL159495A0 (en) Replikin peptides and uses thereof
IL158109A0 (en) Replikin peptides and uses thereof
GB0312990D0 (en) Peptides and uses thereof
GB0323193D0 (en) Peptides and uses thereof
GB0216200D0 (en) Polypeptides and uses thereof
AU2003235099A8 (en) Novel proteins and dnas encoding the same
AU2003227428A8 (en) Novel proteins and dnas encoding the same
AU2003263751A8 (en) Novel proteins and their uses
AU2003303464A8 (en) Centrosome-associated protein and applications thereof